The financial arrangement for the global Phase III program in common warts, where by Verrica and Torii split the cost of the program with the first $40 million funded by Torii has unlocked the ...

Background Cervical cancer is one of the leading causes of death among women in Africa, but stigma often delays cervical ...

Not only is December the holiday season, it's a great time to travel. Here are the best places to travel in December around ...

The Student Council of Gowanda High School named eight outstanding Panthers as Students of the Month for October. Honorees ...

Executive Transition -- CFO Barry Neil Berlin will exit following the lending business sale, with Brandon Hill assuming the ...

Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicine, announced today the publication of foundational research demonstrating the power of its proprietary ...

Katelynne Williams, of Newcastle High School, is The Oklahoman's Student of the Week.

Q3 2025 Earnings Call November 13, 2025 9:00 AM ESTCompany ParticipantsPanna Sharma - President, CEO & DirectorDavid ...

Katapult Holdings, Inc. (NASDAQ: KPLT) Q3 2025 Earnings Call Transcript November 12, 2025 Katapult Holdings, Inc. beats ...

Progressing Phase 2 studies for ratutrelvir, a ritonavir-free, protease inhibitor regimen in development for Acute and Long ...

Cassava Sciences, Inc. (NASDAQ: SAVA, "Cassava", the "Company"), a biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders such as ...